Several lines of evidence suggest that patients with essential hypertension have impaired endothelial nitric oxide activity and increased superoxide anion production. However, the mechanisms underlying these abnormalities remain unknown. We measured enzymatic superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities in erythrocytes and whole blood, respectively, in 30 newly-diagnosed, normolipidaemic untreated mild hypertensive patients and in 164 age-matched healthy controls. SOD and GPX activities in hypertensive patients (806 ؎ 225 U/Hb.g and 5491 ؎ 2073 U/L, respectively) were significantly lower
Introduction
Hypertension has been associated with impaired balance between nitric oxide and reactive oxygen species, with deleterious enhanced oxidative stress being the most important consequence. [1] [2] [3] It has been reported that low-density lipoproteins are more oxidized in vivo and are more susceptible to oxidation in vitro in hypertensive patients than in normotensive subjects. 4 Kumar and Das 5 demonstrated that stimulated leukocytes isolated from hypertensive patients generate more hydrogen peroxide (H 2 O 2 ) and superoxide anion free radicals than those isolated from normal subjects. The biological effects of these highly-reactive compounds are controlled in vivo by a wide spectrum of nonenzymatic and enzymatic antioxidant mechanisms. Among the latter, superoxide dismutase (SOD) catalyzes dismutation of the superoxide anion into H 2 O 2 , catalase detoxifies H 2 O 2 and glutathione peroxidase (GPX) both detoxifies H 2 O 2 and converts lipid hydroperoxides into non-toxic alcohols. 6 The aim of this study was to assess SOD and GPX activities in normolipidaemic patients with untreated essential hypertension and examine the possible relationship between these enzyme activities and blood pressure levels. 
Subjects and methods

Subjects
The study included 30 newly-diagnosed, normolipidaemic (total serum cholesterol and triglyceride concentrations lower than 5.2 mmol/L and 2.3 mmol/L, respectively) untreated hypertensive patients (stages 1 and 2 according to the JNC-V report, 7 systolic blood pressure 140-179 mm Hg and/or diastolic 90-109 mm Hg) and 164 healthy age-matched controls with no first-degree family history of hypertension. Blood pressure was measured after sitting and 10 min rest in a quiet room by the same physician (JP-B) using a 1042 RIESTER sphygmomanometer (Jungingen, FRG), with diastolic pressures at Korotkoff phase 5 (disappearence of sounds). Systolic blood pressure in hypertensive patients and controls ranged from 120 to 175 mm Hg and from 80 to 135 mm Hg, and diastolic from 80 to 105 mm Hg and from 50 to 80 mm Hg, respectively. Among patients, seven had isolated systolic hypertension, two only had increased diastolic blood pressure and 21 elevated systolic-diastolic blood pressure. None of the patients had diabetes mellitus, liver, kidney or endocrine disease or had presented cardiovascular events. The control group was judged free of any illness by history, clinical examination, electrocardiography and routine laboratory data. Exclusion criteria for patients and controls were body mass index above 25, smoking, alcohol consumption over 30 g/day, or being on drug therapy, including vitamin supplement, known to cause changes in antioxidant or lipid status. Subjects were from the same geographical area and none were fol- lowing a special diet. Table 1 shows the characteristics of hypertensive patients and healthy controls.
Measurements
SOD activity in erythrocytes was measured by inhibition rate of 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride reduction (Ransod SD 125, Randox Lab, Crumlin, UK). GPX activity in whole blood was determined by a modification of the method of Paglia and Valentine 8 (Ransel RS 505, Randox Lab). Enzyme activities were quantified at 37°C in a Cobas Mira Plus analyzer (Hoffmann-La Roche, Basel, Switzerland). Haemoglobin concentration was determined with a Sysmex K1000 hematological analyzer (Toa Electronics, Kobe, Japan).
Statistical analysis
Data were expressed as mean ± standard deviation. Distribution of GPX data was normal. However, a logarithmic transformation was required to normalise the SOD distribution data. Unpaired Student's ttest was used to assess statistical differences between groups. Correlations were determined by linear regression analysis. A P value Ͻ0.05 was considered significant.
Results
SOD and GPX activities were significantly lower in hypertensive patients compared with controls (Table 2) . A significant negative correlation between log-transformed SOD activities and systolic and diastolic blood pressure was observed in hypertensive patients (r = 0.37, P Ͻ 0.05; r = 0.64, P Ͻ 0.0001, respectively) ( Figure 1 ). However, no relationship was found between GPX activity and blood pressure or SOD activity. Furthermore, no significant correlation between antioxidant enzyme activities and blood pressure was found in normotensive controls. 
Discussion
Reactive oxygen species such as superoxide radical, H 2 O 2 and hydroxyl radical play an important role in the pathogenesis of hypertension and atherosclerosis. Only in two previous studies, 9,10 has a reduction in erythrocyte SOD activity in patients with essential hypertension been reported. The significantly lower SOD and GPX activities found in hypertensive patients compared with controls could reflect inactivation of these free radical scavengers in a situation of increased oxidative stress or reduced production, thereby rendering an individual more susceptible to damage. Independently of the mechanism, these results suggest that an imbalance exists between the damaging effects and the bioscavenging capability of superoxide and other reactive oxygen species. Moreover, endotheliumdependent relaxation is impaired in hypertensive patients owing to abnormal endothelial nitric oxide availability. 11 Nitric oxide is rapidly inactivated by the superoxide anion. Since the protective scavenging function against superoxide is provided mainly by SOD, the low SOD levels observed in hypertensive patients of the present study could in turn be related to impaired endothelial function as a consequence of reduced superoxide anion removal. 12 The negative association found between blood pressure and SOD activity in hypertensive patients reinforces this hypothesis. It must be taken into account that it remains unknown whether low SOD in erythrocyte levels reflect low endothelial function. However, intravenous SOD injection reduces arterial pressure in spontaneously-hypertensive, but not in normal, rats. 13 In conclusion, patients with mild-to-moderate hypertension show low endogenous antioxidant enzyme activities. This may contribute to rendering the arterial wall more susceptible to oxidative injury in essential hypertension.
